• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏植入式电子设备患者中三尖瓣反流的患病率及其预后影响:来自澳大利亚国家超声心动图数据库

Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of Australia.

作者信息

Offen Sophie, Strange Geoff, Playford David, Celermajer David S, Stewart Simon

机构信息

Faculty of Medicine and Health, University of Sydney, NSW, Australia; Dept of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Heart Research Institute, Sydney, NSW, Australia; The University of Notre Dame Australia, Fremantle, WA, Australia.

出版信息

Int J Cardiol. 2023 Jan 1;370:338-344. doi: 10.1016/j.ijcard.2022.10.160. Epub 2022 Oct 29.

DOI:10.1016/j.ijcard.2022.10.160
PMID:36346256
Abstract

AIMS

We sought to analyse the distribution of TR severity and survival in a large cohort of adults with CIED leads.

METHODS

The distribution of TR severity was analysed in 18,797 adults (mean age 73.8+/-13.9, 63.3% men) with CIED leads undergoing echocardiography across 25 centres. Survival status and cause of death were linked and the relationship between TR severity and mortality during 2.6 (interquartile range 1.1-4.6) years follow-up examined. Data from 439,558 individuals (mean age 62.1 ±17.8 years, 51.5% men) without a CIED were subsequently incorporated in a pooled cohort analysis.

RESULTS

Overall, 8,824/18,797 individuals (47%) with a CIED had no/trivial TR; 5,490 (29.2%) mild TR; 3,068 (16.3%) moderate TR; and 1,415 (7.5%) severe TR. Moderate or greater TR was independently associated with age, female sex, atrial fibrillation and significant left heart disease (p<0.001 for all). 8,868 individuals (47.2%) died from any cause (43.2% from cardiovascular causes). Individuals with moderate or severe TR had a 1.6 to 2.5-fold increased risk of all-cause mortality in adjusted models, compared to those with no TR (p<0.001 for both). In the pooled cohort analysis, CIEDs were associated with a near 2-fold (95% CI 1.81-1.99; p<0.001) increased probability of moderate or greater TR, on adjusted basis. However, the mortality associated with moderate or greater TR did not differ significantly with respect to the presence or absence of a device lead.

CONCLUSIONS

Moderate or greater TR is more prevalent in those with CIED's, even in adjusted models, and was independently associated with incremental risks for all-cause and cardiovascular mortality.

摘要

目的

我们试图分析一大群有心脏植入电子设备(CIED)导联的成年人中三尖瓣反流(TR)严重程度的分布及生存率。

方法

在25个中心对18797名有CIED导联且接受超声心动图检查的成年人(平均年龄73.8±13.9岁,男性占63.3%)的TR严重程度分布进行分析。将生存状态和死亡原因相关联,并在2.6年(四分位间距1.1 - 4.6年)的随访期间检查TR严重程度与死亡率之间的关系。随后将来自439558名无CIED的个体(平均年龄62.1±17.8岁,男性占51.5%)的数据纳入汇总队列分析。

结果

总体而言,18797名有CIED的个体中,8824名(47%)无/微量TR;5490名(29.2%)轻度TR;3068名(16.3%)中度TR;1415名(7.5%)重度TR。中度或更严重的TR与年龄、女性性别、心房颤动和显著的左心疾病独立相关(所有p<0.001)。8868名个体(47.2%)死于任何原因(43.2%死于心血管原因)。与无TR的个体相比,中度或重度TR个体在调整模型中的全因死亡率风险增加1.6至2.5倍(两者p<0.001)。在汇总队列分析中,经调整后,CIED与中度或更严重TR的发生概率增加近2倍(95%置信区间1.81 - 1.99;p<0.001)相关。然而,与中度或更严重TR相关的死亡率在有无设备导联方面无显著差异。

结论

即使在调整模型中,中度或更严重的TR在有CIED的个体中更普遍,并且与全因和心血管死亡率的增加风险独立相关。

相似文献

1
Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of Australia.心脏植入式电子设备患者中三尖瓣反流的患病率及其预后影响:来自澳大利亚国家超声心动图数据库
Int J Cardiol. 2023 Jan 1;370:338-344. doi: 10.1016/j.ijcard.2022.10.160. Epub 2022 Oct 29.
2
Adverse Prognostic Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from the National Echocardiography Database of Australia.即使是轻度或中度三尖瓣反流也有不良预后影响:来自澳大利亚国家超声心动图数据库的见解。
J Am Soc Echocardiogr. 2022 Aug;35(8):810-817. doi: 10.1016/j.echo.2022.04.003. Epub 2022 Apr 12.
3
Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.心脏植入式电子设备后三尖瓣和二尖瓣反流的演变和预后:系统评价和荟萃分析。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae143.
4
Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting.社区诊断患者的三尖瓣反流负担。
JACC Cardiovasc Imaging. 2019 Mar;12(3):433-442. doi: 10.1016/j.jcmg.2018.06.014. Epub 2018 Aug 15.
5
Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.心脏植入式电子设备引起的三尖瓣反流:影响和管理。
J Cardiovasc Electrophysiol. 2024 May;35(5):1017-1025. doi: 10.1111/jce.16251. Epub 2024 Mar 19.
6
Functional Tricuspid Regurgitation After Transcatheter Closure of Atrial Septal Defect in Adult Patients: Long-Term Follow-Up.成人房间隔缺损经导管封堵术后功能性三尖瓣反流:长期随访。
JACC Cardiovasc Interv. 2017 Nov 13;10(21):2211-2218. doi: 10.1016/j.jcin.2017.06.022. Epub 2017 Oct 18.
7
Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study.慢性心房颤动所致功能性三尖瓣反流:一项实时三维经食管超声心动图研究
Circ Cardiovasc Imaging. 2017 Jan;10(1). doi: 10.1161/CIRCIMAGING.116.004897.
8
Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results.心脏植入式电子设备患者三尖瓣反流的外科治疗:长期结果。
Eur J Cardiothorac Surg. 2022 Aug 3;62(3). doi: 10.1093/ejcts/ezac239.
9
Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.心脏植入式电子设备植入后三尖瓣反流的发生率、危险因素和预后:系统评价和荟萃分析。
J Cardiothorac Vasc Anesth. 2022 Jun;36(6):1741-1755. doi: 10.1053/j.jvca.2021.06.025. Epub 2021 Jun 25.
10
Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.心脏装置植入术后三尖瓣反流和心包积液的超声心动图评估。
Cardiol J. 2020;27(6):797-806. doi: 10.5603/CJ.a2019.0053. Epub 2019 Jun 21.

引用本文的文献

1
[Research of tricuspid regurgitation associated with cardiac implantable electronic devices].[心脏植入式电子装置相关三尖瓣反流的研究]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Mar 25;54(2):219-229. doi: 10.3724/zdxbyxb-2024-0396.
2
Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society.经导管三尖瓣介入治疗中经瓣右心室导线患者的管理:欧洲心脏节律协会和欧洲心脏病学会经皮心血管介入协会的科学声明,得到心律学会、亚太心脏节律学会和加拿大心脏节律学会认可
Europace. 2025 May 7;27(5). doi: 10.1093/europace/euaf061.
3
Tricuspid Regurgitation in the Setting of Cardiac Implantable Electronic Devices.心脏植入式电子设备相关的三尖瓣反流
Struct Heart. 2024 May 22;9(1):100319. doi: 10.1016/j.shj.2024.100319. eCollection 2025 Jan.
4
Tricuspid Regurgitation Associated with Implantable Cardiac Devices: A Double-Edged Sword.与植入式心脏装置相关的三尖瓣反流:一把双刃剑。
J Clin Med. 2024 Sep 19;13(18):5543. doi: 10.3390/jcm13185543.
5
First Case of the Treatment of Massive Tricuspid Regurgitation With the CroíValve DUO Coaptation Valve in a Patient With a Right Ventricular Pacemaker Lead.首例使用CroíValve DUO贴合瓣膜治疗右心室起搏器导线患者的严重三尖瓣反流。
Struct Heart. 2024 Jun 25;8(5):100329. doi: 10.1016/j.shj.2024.100329. eCollection 2024 Sep.
6
Tricuspid Valve Leaflets-Lead Interaction: Adjunctive Role of Functional Cardiac Computed Tomography for Clinical Decision Making.三尖瓣小叶与导线相互作用:功能性心脏计算机断层扫描在临床决策中的辅助作用。
JACC Case Rep. 2024 May 12;29(12):102372. doi: 10.1016/j.jaccas.2024.102372. eCollection 2024 Jun 19.
7
Tricuspid valve disease and cardiac implantable electronic devices.三尖瓣疾病与心脏植入式电子设备。
Eur Heart J. 2024 Feb 1;45(5):346-365. doi: 10.1093/eurheartj/ehad783.
8
Tricuspid Regurgitation (TR) after Implantation of a Cardiac Implantable Electronic Device (CIED)-One-Year Observation of Patients with or without Left Ventricular Dysfunction.心脏植入式电子设备(CIED)植入术后的三尖瓣反流(TR)——对有或无左心室功能障碍患者的一年观察
J Cardiovasc Dev Dis. 2023 Aug 19;10(8):353. doi: 10.3390/jcdd10080353.